Zylö Therapeutics
Startup
Summarized by Halo AI
Zylö Therapeutics is a drug delivery company partnering with the pharmaceutical, OTC, cosmetic, and animal health sectors to improve product efficacy and solve delivery challenges.
Founded & HQ
Greenville, SC, USA
Activity highlights
Awarded a $300,000 Phase 1 SBIR grant by the NIH for an endocannabinoid microparticle formulation for cutaneous lupus erythematosus treatment.
A US-based startup focusing on sustained-release drug delivery for topical applications. Known for its Z-pod technology, it aims to improve patient outcomes and convenience through advanced encapsulation of therapeutic and cosmetic agents.
AI summary generated on Jun 4, 2026
OpenAlex
OpenAlexFor general inquiries
CH
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.
Looking for
Co-developmentSupply/purchaseLicensingFee-for-servicePilot or trial engagement
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.